It is possible that the expected loss of function in TREM2 conferred by p.R47H may underlie the lower levels of TSPO signal seen in the TREM2 p.R47H carriers and that this reduced microglial activation may be a factor in the increased risk of Alzheimer’s disease in these carriers. This evidence concerns the gene TSPO and Alzheimer disease.